Two Class Actions Target Supplement Promoted for Increasing GLP-1 Friday, April 4, 2025 A plaintiff has filed two class actions targeting a dietary supplement promoted as increasing GLP-1
Tang Z, Shu L, Cao Z, Xu Y, Li C (2024) Osteoarthritis rat serum-derived extracellular vesicles aggravate osteoarthritis development by inducing NLRP3-mediated pyroptotic cell death and cellular inflammation
Although how exactly these drugs help in weight loss is not known, as GLP-1 agonists slow the movement of food traveling from the stomach to the small intestine, it makes people feel full quicker and for longer, and so, it is thought to boost weight loss because people tend to eat less as result of the medication
This is personalized medicineyour genetic blueprint informs dosing strategy, not a one-size-fits-all protocol